234 related articles for article (PubMed ID: 31439947)
1. Crystal structure and substrate-induced activation of ADAMTS13.
Petri A; Kim HJ; Xu Y; de Groot R; Li C; Vandenbulcke A; Vanhoorelbeke K; Emsley J; Crawley JTB
Nat Commun; 2019 Aug; 10(1):3781. PubMed ID: 31439947
[TBL] [Abstract][Full Text] [Related]
2. Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation.
Muia J; Zhu J; Greco SC; Vanhoorelbeke K; Gupta G; Westfield LA; Sadler JE
Blood; 2019 Apr; 133(17):1899-1908. PubMed ID: 30700419
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13).
Xiang Y; de Groot R; Crawley JT; Lane DA
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11602-7. PubMed ID: 21705658
[TBL] [Abstract][Full Text] [Related]
4. Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease.
Gao W; Anderson PJ; Majerus EM; Tuley EA; Sadler JE
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19099-104. PubMed ID: 17146059
[TBL] [Abstract][Full Text] [Related]
5. Exploring the "minimal" structure of a functional ADAMTS13 by mutagenesis and small-angle X-ray scattering.
Zhu J; Muia J; Gupta G; Westfield LA; Vanhoorelbeke K; Tolia NH; Sadler JE
Blood; 2019 Apr; 133(17):1909-1918. PubMed ID: 30692120
[TBL] [Abstract][Full Text] [Related]
6. Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function.
Schelpe AS; Petri A; Roose E; Pareyn I; Deckmyn H; De Meyer SF; Crawley JTB; Vanhoorelbeke K
Blood Adv; 2020 Mar; 4(6):1072-1080. PubMed ID: 32196558
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin.
Chen J; Ling M; Fu X; López JA; Chung DW
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2625-30. PubMed ID: 22922961
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor.
Akiyama M; Takeda S; Kokame K; Takagi J; Miyata T
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19274-9. PubMed ID: 19880749
[TBL] [Abstract][Full Text] [Related]
9. A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor.
South K; Freitas MO; Lane DA
J Biol Chem; 2017 Apr; 292(14):5760-5769. PubMed ID: 28209710
[TBL] [Abstract][Full Text] [Related]
10. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.
Crawley JT; de Groot R; Xiang Y; Luken BM; Lane DA
Blood; 2011 Sep; 118(12):3212-21. PubMed ID: 21715306
[TBL] [Abstract][Full Text] [Related]
11. Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity.
Gao W; Anderson PJ; Sadler JE
Blood; 2008 Sep; 112(5):1713-9. PubMed ID: 18492952
[TBL] [Abstract][Full Text] [Related]
12. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.
Nishio K; Anderson PJ; Zheng XL; Sadler JE
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10578-83. PubMed ID: 15249683
[TBL] [Abstract][Full Text] [Related]
13. N-linked glycan stabilization of the VWF A2 domain.
Lynch CJ; Lane DA
Blood; 2016 Mar; 127(13):1711-8. PubMed ID: 26773038
[TBL] [Abstract][Full Text] [Related]
14. Allosteric activation of ADAMTS13 by von Willebrand factor.
Muia J; Zhu J; Gupta G; Haberichter SL; Friedman KD; Feys HB; Deforche L; Vanhoorelbeke K; Westfield LA; Roth R; Tolia NH; Heuser JE; Sadler JE
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18584-9. PubMed ID: 25512528
[TBL] [Abstract][Full Text] [Related]
15. The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis.
de Groot R; Lane DA; Crawley JT
Blood; 2015 Mar; 125(12):1968-75. PubMed ID: 25564400
[TBL] [Abstract][Full Text] [Related]
16. Rearranging exosites in noncatalytic domains can redirect the substrate specificity of ADAMTS proteases.
Gao W; Zhu J; Westfield LA; Tuley EA; Anderson PJ; Sadler JE
J Biol Chem; 2012 Aug; 287(32):26944-52. PubMed ID: 22707719
[TBL] [Abstract][Full Text] [Related]
17. A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF.
Zanardelli S; Chion AC; Groot E; Lenting PJ; McKinnon TA; Laffan MA; Tseng M; Lane DA
Blood; 2009 Sep; 114(13):2819-28. PubMed ID: 19587373
[TBL] [Abstract][Full Text] [Related]
18. Essential role of the disintegrin-like domain in ADAMTS13 function.
de Groot R; Bardhan A; Ramroop N; Lane DA; Crawley JT
Blood; 2009 May; 113(22):5609-16. PubMed ID: 19234142
[TBL] [Abstract][Full Text] [Related]
19. A conformation-sensitive monoclonal antibody against the A2 domain of von Willebrand factor reduces its proteolysis by ADAMTS13.
Zhang J; Ma Z; Dong N; Liu F; Su J; Zhao Y; Shen F; Wang A; Ruan C
PLoS One; 2011; 6(7):e22157. PubMed ID: 21779388
[TBL] [Abstract][Full Text] [Related]
20. Identification of cysteine thiol-based linkages in ADAMTS13 in support of a non-proteolytic regulation of von Willebrand factor.
Rottensteiner H; Seyfried BK; Kaufmann S; Fiedler C; Dong JF; Zheng XL; Plaimauer B; Scheiflinger F
J Thromb Haemost; 2019 Dec; 17(12):2099-2109. PubMed ID: 31393047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
